Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 1

Healio

Patients with immune-mediated inflammatory diseases receiving B-cell depleting therapies are at risk for COVID-19 regardless of vaccine status, but outpatient use of monoclonal antibodies